Enterprise Scaler

Choose the right bioproducts to transform your business.

GET A DEMO

What is Techno-Economic Analysis?

The market for bioproducts is fast-growing, but how can businesses quickly and accurately evaluate a product's long-term viability?

Techno-Economic Analyses (TEAs) help enterprises understand the holistic production costs of bioproducts. This crucial step in raw material evaluation helps businesses maximize upside and minimize risks as they adopt novel materials.

With Scaler, evaluate them faster and more rigorously than ever before.

What do you get with Scaler?

Production & Financial Model

Dynamic model customized to your bioprocess

Mass & Energy Balance

Sized & Priced Equipment List

Utility Summary

COGS Breakdown

CapEx Breakdown

Analysis & Insights

Summary of key analyses and commentary to inform business decisions

Total Project Cost Overview

Sensitivity Analyses

Identify Key Cost Drivers

COGS Commentary

CapEx Commentary

How Scaler delivers the best TEA available

Comprehensive

Includes more than 70 technology, commercial and operational variables (titers, fermentation times, product pricing, facility sizes and more)

Customizable

An integrated CapEx and OpEx model that dynamically updates as you adjust variables.

Expert

Synonym's team has decades of biomanufacturing experience, from leading firms including Jacobs, Merrick, Cargill and Dupont.

Scenario Analysis

Considers various scenarios and sensitivities to quantify risks and uncertainties associated with the technology

Cloud Based

Online portal that facilitates secure access from any device and allows users to work remotely or collaborate across multiple locations.

Accurate

Captures all meaningful costs associated with first of a kind projects that are often missed (cost of capital, construction indirects, project guarantees)

Everyone needs
Scaler to assess
if a technology can compete on process performance
and price

Synonym's Insights helped us define our production scale-up strategy. Their COGS calculations gave us a clear view into what our price curve could look like as we scale.
Arturo Elizondo
CEO, The EVERY Company
By providing startups with a way to effectively value the feasibility of their technology and de-risk the scalability, Synonym Bio's Scaler tool is a major disrupter in the life sciences/biotech space. The result is a high-value, TEA model that effectively communicates a startup's economic viability.
Anne Palermo
CEO, Aqua Cultured Foods
It’s already pretty awesome and this could really change the conversation around the biomanufacturing industry! It’s so useful to have a quick tool to put numbers around intuitions and understand what needs to change to get to target COGS.
Friederike Grosse-Holz
Director, Blue Horizon
Synonym's Insights helped us define our production scale-up strategy. Their COGS calculations gave us a clear view into what our price curve could look like as we scale.
Arturo Elizondo
CEO, The EVERY Company
By providing startups with a way to effectively value the feasibility of their technology and de-risk the scalability, Synonym Bio's Scaler tool is a major disrupter in the life sciences/biotech space. The result is a high-value, TEA model that effectively communicates a startup's economic viability.
Anne Palermo
CEO, Aqua Cultured Foods
It’s already pretty awesome and this could really change the conversation around the biomanufacturing industry! It’s so useful to have a quick tool to put numbers around intuitions and understand what needs to change to get to target COGS.
Friederike Grosse-Holz
Director, Blue Horizon
Synonym's Insights helped us define our production scale-up strategy. Their COGS calculations gave us a clear view into what our price curve could look like as we scale.
Arturo Elizondo
CEO, The EVERY Company
By providing startups with a way to effectively value the feasibility of their technology and de-risk the scalability, Synonym Bio's Scaler tool is a major disrupter in the life sciences/biotech space. The result is a high-value, TEA model that effectively communicates a startup's economic viability.
Anne Palermo
CEO, Aqua Cultured Foods
It’s already pretty awesome and this could really change the conversation around the biomanufacturing industry! It’s so useful to have a quick tool to put numbers around intuitions and understand what needs to change to get to target COGS.
Friederike Grosse-Holz
Director, Blue Horizon
Synonym's Insights helped us define our production scale-up strategy. Their COGS calculations gave us a clear view into what our price curve could look like as we scale.
Arturo Elizondo
CEO, The EVERY Company
By providing startups with a way to effectively value the feasibility of their technology and de-risk the scalability, Synonym Bio's Scaler tool is a major disrupter in the life sciences/biotech space. The result is a high-value, TEA model that effectively communicates a startup's economic viability.
Anne Palermo
CEO, Aqua Cultured Foods
It’s already pretty awesome and this could really change the conversation around the biomanufacturing industry! It’s so useful to have a quick tool to put numbers around intuitions and understand what needs to change to get to target COGS.
Friederike Grosse-Holz
Director, Blue Horizon

Synonym's Insights helped us define our production scale-up strategy. Their COGS calculations gave us a clear view into what our price curve could look like as we scale.
Arturo Elizondo
CEO, The EVERY Company
By providing startups with a way to effectively value the feasibility of their technology and de-risk the scalability, Synonym Bio's Scaler tool is a major disrupter in the life sciences/biotech space. The result is a high-value, TEA model that effectively communicates a startup's economic viability.
Anne Palermo
CEO, Aqua Cultured Foods
It’s already pretty awesome and this could really change the conversation around the biomanufacturing industry! It’s so useful to have a quick tool to put numbers around intuitions and understand what needs to change to get to target COGS.
Friederike Grosse-Holz
Director, Blue Horizon
It’s already pretty awesome and this could really change the conversation around the biomanufacturing industry! It’s so useful to have a quick tool to put numbers around intuitions and understand what needs to change to get to target COGS.
Friederike Grosse-Holz
Director, Blue Horizon
By providing startups with a way to effectively value the feasibility of their technology and de-risk the scalability, Synonym Bio's Scaler tool is a major disrupter in the life sciences/biotech space. The result is a high-value, TEA model that effectively communicates a startup's economic viability.
Anne Palermo
CEO, Aqua Cultured Foods
Synonym's Insights helped us define our production scale-up strategy. Their COGS calculations gave us a clear view into what our price curve could look like as we scale.
Arturo Elizondo
CEO, The EVERY Company
Synonym's Insights helped us define our production scale-up strategy. Their COGS calculations gave us a clear view into what our price curve could look like as we scale.
Arturo Elizondo
CEO, The EVERY Company
By providing startups with a way to effectively value the feasibility of their technology and de-risk the scalability, Synonym Bio's Scaler tool is a major disrupter in the life sciences/biotech space. The result is a high-value, TEA model that effectively communicates a startup's economic viability.
Anne Palermo
CEO, Aqua Cultured Foods
It’s already pretty awesome and this could really change the conversation around the biomanufacturing industry! It’s so useful to have a quick tool to put numbers around intuitions and understand what needs to change to get to target COGS.
Friederike Grosse-Holz
Director, Blue Horizon
It’s already pretty awesome and this could really change the conversation around the biomanufacturing industry! It’s so useful to have a quick tool to put numbers around intuitions and understand what needs to change to get to target COGS.
Friederike Grosse-Holz
Director, Blue Horizon
By providing startups with a way to effectively value the feasibility of their technology and de-risk the scalability, Synonym Bio's Scaler tool is a major disrupter in the life sciences/biotech space. The result is a high-value, TEA model that effectively communicates a startup's economic viability.
Anne Palermo
CEO, Aqua Cultured Foods
Synonym's Insights helped us define our production scale-up strategy. Their COGS calculations gave us a clear view into what our price curve could look like as we scale.
Arturo Elizondo
CEO, The EVERY Company
Synonym's Insights helped us define our production scale-up strategy. Their COGS calculations gave us a clear view into what our price curve could look like as we scale.
Arturo Elizondo
CEO, The EVERY Company
By providing startups with a way to effectively value the feasibility of their technology and de-risk the scalability, Synonym Bio's Scaler tool is a major disrupter in the life sciences/biotech space. The result is a high-value, TEA model that effectively communicates a startup's economic viability.
Anne Palermo
CEO, Aqua Cultured Foods
It’s already pretty awesome and this could really change the conversation around the biomanufacturing industry! It’s so useful to have a quick tool to put numbers around intuitions and understand what needs to change to get to target COGS.
Friederike Grosse-Holz
Director, Blue Horizon
It’s already pretty awesome and this could really change the conversation around the biomanufacturing industry! It’s so useful to have a quick tool to put numbers around intuitions and understand what needs to change to get to target COGS.
Friederike Grosse-Holz
Director, Blue Horizon
By providing startups with a way to effectively value the feasibility of their technology and de-risk the scalability, Synonym Bio's Scaler tool is a major disrupter in the life sciences/biotech space. The result is a high-value, TEA model that effectively communicates a startup's economic viability.
Anne Palermo
CEO, Aqua Cultured Foods
Synonym's Insights helped us define our production scale-up strategy. Their COGS calculations gave us a clear view into what our price curve could look like as we scale.
Arturo Elizondo
CEO, The EVERY Company
Synonym's Insights helped us define our production scale-up strategy. Their COGS calculations gave us a clear view into what our price curve could look like as we scale.
Arturo Elizondo
CEO, The EVERY Company
By providing startups with a way to effectively value the feasibility of their technology and de-risk the scalability, Synonym Bio's Scaler tool is a major disrupter in the life sciences/biotech space. The result is a high-value, TEA model that effectively communicates a startup's economic viability.
Anne Palermo
CEO, Aqua Cultured Foods
It’s already pretty awesome and this could really change the conversation around the biomanufacturing industry! It’s so useful to have a quick tool to put numbers around intuitions and understand what needs to change to get to target COGS.
Friederike Grosse-Holz
Director, Blue Horizon
It’s already pretty awesome and this could really change the conversation around the biomanufacturing industry! It’s so useful to have a quick tool to put numbers around intuitions and understand what needs to change to get to target COGS.
Friederike Grosse-Holz
Director, Blue Horizon
By providing startups with a way to effectively value the feasibility of their technology and de-risk the scalability, Synonym Bio's Scaler tool is a major disrupter in the life sciences/biotech space. The result is a high-value, TEA model that effectively communicates a startup's economic viability.
Anne Palermo
CEO, Aqua Cultured Foods
Synonym's Insights helped us define our production scale-up strategy. Their COGS calculations gave us a clear view into what our price curve could look like as we scale.
Arturo Elizondo
CEO, The EVERY Company

Ready to get started?

GET A DEMO

platform@synonym.bio